Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02047396 · ClinicalTrials.gov registry record
Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study
A clinical trial of Heart Failure and Myocardial Infarction, sponsored by Mayo Clinic.
- Active
- Registry status
- 1,599
- Enrollment target
- 1
- Study location
NCT02047396: Active study of Heart Failure and Myocardial Infarction, sponsored by Mayo Clinic.
NCT02047396 is a study of Heart Failure and Myocardial Infarction that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 1,599 participants, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02047396, a study of Heart Failure and Myocardial Infarction, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,599 participants
- Enrollment target
- 1
- Study location
Study Summary
To comprehensively characterize Left Ventricular (LV) remodeling after Myocardial Infarction (MI) in the community, study the association between patterns of remodeling and biological pathways and examine the association between the predictors of remodeling and heart failure after Myocardial Infarction.
Primary Outcome
Development of Heart Failure post Myocardial Infarction
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,599 participants |
| Start Date | 2014-01 |
| Est. Completion | 2030-01 |
What the registry record for NCT02047396 still lists
NCT02047396 is an observational study that tracks outcomes without assigning an intervention. Its 1,599 participants enrollment target places it among the larger protocols in the corpus, below the 2,045-participant average among 397 other Heart Failure trials with a reported enrollment target (22% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT02047396 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02047396 about?
NCT02047396 is a clinical study titled "Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study". To comprehensively characterize Left Ventricular (LV) remodeling after Myocardial Infarction (MI) in the community, study the association between patterns of remodeling and biological pathways and examine the association between the predictors of remodeling and heart failure after Myocardial Infarct...
What is the current status of trial NCT02047396?
This trial is currently active not recruiting. The enrollment target is 1,599 participants. The study started on 2014-01. Estimated completion is 2030-01.
What conditions does trial NCT02047396 study?
This clinical trial studies the following conditions: Heart Failure, Myocardial Infarction.
Who is sponsoring clinical trial NCT02047396?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02047396 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02047396's enrollment target sits among peer trials
1,599 51st of 397 higher than 347 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia